July 24th 2025
The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell carcinoma of the anal canal.
9th Annual School of Nursing Oncology™
August 9, 2025
Register Now!
PER's Satellite Symposia at MHS
August 1-2, 2025
Register Now!
A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and AD...
September 6, 2025
Register Now!
Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?
View More
Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies
View More
Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care
View More
Brain Mets: Brain & Spine Metastases Research and Emerging Therapy Conference
January 22, 2026
Register Now!
2nd Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers
View More
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes
View More
11th Annual School of Gastrointestinal Oncology® (SOGO®)
April 11, 2026
Register Now!
Addressing Unmet Needs in HER2+ Metastatic BTC
View More
Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer
View More
From Bench to Bedside: Paradigm Shifts in HER2+ Metastatic BTC Treatment
View More
Proactive Adverse Event Management for HER2+ BTC Treatments
View More
GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer
View More
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
View More
Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma
View More
Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma
View More
Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches
View More
Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer
View More
"Hotspots" Highlight Need for Targeted Efforts to Promote Colorectal Cancer Screening
July 8th 2015Researchers have identified three "hotspots" in the United States where progress on reducing death rates from colorectal cancer have lagged, shining a light on areas of the country where efforts to increase screening uptake and promote healthier lifestyles could make a big difference.
Susan Mazanec on Activation for Health Management
April 28th 2015Susan R. Mazanec, PhD, RN, AOCN, Research Assistant Professor, Frances Payne Bolton School of Nursing, Case Western Reserve University, discusses a study that examined activation for health management in colorectal cancer patients and their family caregivers during the transition to post-treatment survivorship.
What Is Lynch Syndrome and Why Is It Important?
April 28th 2015Lynch syndrome (LS) is a hereditary syndrome that causes a marked increased risk of colorectal and other cancers. It is inherited in an autosomal dominant pattern, which means that it is due to a mutation in one copy of a gene (in LS, a DNA mismatch repair gene).
"Welcome to the Walk-through Colon" and Other GI Navigation Success Stories
April 27th 2015Oncology nurse navigators are known for identifying gaps in cancer care, being proactive in setting goals to address them, and designing specific interventions that lead not only to better-and measurable-outcomes but also to increased patient satisfaction.
Carmela Hoefling on Understanding Pancreatic Cancer
April 14th 2015Carmela Hoefling, RN, MSN, APN-C, AOCNP, advanced practice nurse, Gastrointestinal/Hepatobiliary Oncology Program, Rutgers Cancer Institute of New Jersey, discusses the findings of a project on pancreatic treatment, care, and risk factors.
High Fitness Level in Older Men Associated with Lower Risk of Some Cancers
March 27th 2015A new study has shown that men with a high fitness level in midlife are not only at a lower risk of developing lung and colorectal cancer, they're also at a lower risk of dying from cancer if they're diagnosed later in life.
NO STOMACH FOR CANCER: Founded by a Family, for the Empowerment of Families
March 13th 2015Karen Chelcun Schreiber was first touched by gastric cancer in 1982, when her mother Elaine died of the disease at age 52. She was impacted again in 2007 when her brother Greg was diagnosed with Stage IV gastric cancer. He was 56.
Carmela Hoefling, RN, Discusses the Challenges of Treating Patients with Pancreatic Cancer
March 13th 2015Carmela Hoefling, RN, MSN, APN-C, AOCNP, advanced practice nurse, Gastrointestinal/Hepatobiliary Oncology Program, Rutgers Cancer Institute of New Jersey, discusses some of the challenges that nurses face when treating patients who have been diagnosed with pancreatic cancer.
Less Frequent Dosing of Pancreatic Cancer Regimen Effective, Less Toxic
January 19th 2015Changing the administration schedule for gemcitabine plus nab-paclitaxel (Abraxane) from weekly to every other week significantly reduced side effects without impacting efficacy as a frontline treatment for patients with metastatic pancreatic cancer, according to a retrospective study presented at the 2015 GI Cancers Symposium.
Investigators Find Potential Genetic Clues to Disparities in Colon Cancer
January 13th 2015Researchers from the Case Comprehensive Cancer Center have discovered new gene mutations that are unique to colon cancer in African American patients, who have the highest incidence and death rate from the disease.
Vitamin D Demonstrates Multiple Benefits for Patients With mCRC
January 12th 2015Patients with newly diagnosed metastatic colorectal cancer (mCRC) who had higher levels of vitamin D in their blood lived a median of 8 months longer and experienced greater disease-free survival after their cancer treatment
Studies Forecast More CRC in Young Adults and Find Higher Mortality Among the Least Educated
November 20th 2014Findings from two studies are shining a light on demographic and socioeconomic factors impacting who will be diagnosed with colorectal cancer (CRC), who is more likely to die from it, and what preventive measures might make a difference.
Case-Based, Weekly Tumor Boards May Improve Survival and Boost Clinical Trial Participation
October 14th 2014Patients with certain lung and colorectal cancers whose physicians participated in weekly, treatment-focused tumor board meetings had improved survival and were 60% more likely to enroll in a clinical trial
Proactively Managing Treatment-Related Adverse Events in Advanced Colorectal Cancer
October 9th 2014As new therapies enter the treatment landscape for metastatic disease, the role of the oncology nurse becomes even more critical in educating patients about what side effects to look out for and the importance of reporting any adverse events promptly.